EXL Share Price Performance
€2.53
0.47 (22.82%)
50.4% undervalued intrinsic discount
€5.10
Fair Value
Price €2.53
AnalystConsensusTarget €5.10
Fair Value€5.10
Share Pricen/a
Returns Are Gaining Momentum At Exasol (ETR:EXL)
Aug 17
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 19 Fair Values set on narratives written by author
EXL Community Narratives
AN
Fair Value €5.1 50.4% undervalued intrinsic discount
Hybrid Analytics Will Serve Finance And Healthcare Markets
0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
Hybrid Analytics Will Serve Finance And Healthcare Markets
Key Takeaways Strategic focus on regulated industries and hybrid solutions positions Exasol for niche market growth while leveraging data repatriation trends for increased revenue. Cost-efficient strategies and new AI capabilities support profitability and competitive advantage, enhancing scalability and ARR growth in target regions.Read more
0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
AN
€5.1
50.4% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
8.48% p.a.
Profit Margin
11.9%
Future PE
25.13x
Share price in 2028
€5.98
Recently Updated Narratives
AN
Hybrid Analytics Will Serve Finance And Healthcare Markets
Fair Value: €5.1 50.4% undervalued intrinsic discount
7 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Exasol AG Key Details
About EXL
- Founded
- 2000
- Employees
- 157
- CEO
- WebsiteView website
Exasol AG, a technology company, engages in the provision of an analytics engine to access and analyze a company’s data in Germany, Austria, Switzerland, Rest of Europe, United Kingdom, and Region America. The company offers Exasol analytics engine, an in-memory engine designed for near real-time analytics, data warehousing, and AI/ML workloads. It serves e-commerce and retail, banking and insurance, hedge funds, and healthcare and pharma industries. Exasol AG was founded in 2000 and is headquartered in Nuremberg, Germany.
